This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2024!
March 11-14, 2024Town and Country Resort, San Diego

Greg Deener
Chief Executive Officer at iCell Gene Therapeutics
Speaker

Profile

Greg Deener is CEO of iCell Gene Therapeutics. Greg has had numerous leadership roles at both large corporations (GSK, P&G) as well as earlier stage biotechs (GTx, Sucampo). iCell Gene Therapeutics was founded by Professor Yupo Ma, MD, PhD. Professor Ma is on faculty at Stony Brook as a hematopathologist. iCell began in 2014. The company model is to patent potentially best in class technology (iCell has >100 granted/allowed cell therapy patents), demonstrate the proof of concept in China and then begin full development.

Agenda Sessions

  • Importance of targeting both B cells and plasma cells to safely achieve immune reset and medication-free long-term remission; iCell CAR data in autoimmune disease

    10:30am
  • Importance of targeting both B cells and plasma cells to safely achieve immune reset and medication-free long-term remission; iCell CAR data in autoimmune disease

    10:30am